Bolejko Anetta, Hagell Peter, Wann-Hansson Christine, Zackrisson Sophia
Department of Medical Imaging and Physiology, Skåne University Hospital Malmö, Malmö, Sweden.
The PRO-CARE Group, School of Health and Society, Kristianstad University, Kristianstad, Sweden.
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1388-97. doi: 10.1158/1055-9965.EPI-15-0060.
Cancer screening aims to detect cancer at an asymptomatic stage, although side effects from screening also occur. We investigated the prevalence, longitudinal development, and predictors of psychosocial consequences of false-positive breast cancer screening.
Three hundred ninety-nine women with false-positive screening mammography responded to the Consequences of Screening-Breast Cancer (COS-BC) questionnaire immediately after a negative diagnosis (free from breast cancer) following recall examination(s) (baseline), and 6 and 12 months later. Age-matched controls (n = 499) with a negative mammogram responded to the COS-BC at the same occasions. Five COS-BC scales (Sense of dejection, Anxiety, Behavioral, Sleep, and Existential values) were used as outcome measures.
Women with false-positive mammography had consistently higher prevalence of all five consequences compared with controls (P < 0.001). The prevalences decreased between baseline and 6 months (P < 0.001) but were stable between 6 and 12 months (P ≥ 0.136). Early recall profoundly predicted long-term consequences for all five outcomes (OR, 3.05-10.31), along with dissatisfaction with information at recall (OR, 2.28-2.56), being foreign-born (OR, 2.35-3.71), and lack of social support (OR, 1.13-1.25).
This 1-year longitudinal study shows that women experience psychosocial consequences of false-positive screening mammography. Early recall should be performed cautiously, and provision of information as well as social support may reduce psychosocial consequences.
Although delivery of population-based screening reduces breast cancer mortality, it also raises the issue of its impact on the psychosocial well-being of healthy women. Our findings identify predictors that can be targeted in future efforts to reduce the side effects of mammographic screening.
癌症筛查旨在在无症状阶段检测出癌症,不过筛查也会产生副作用。我们调查了乳腺癌筛查假阳性的心理社会后果的患病率、纵向发展情况及预测因素。
399名乳腺钼靶筛查结果为假阳性的女性在召回检查(基线)后确诊为阴性(无乳腺癌)后立即、6个月后和12个月后对乳腺癌筛查后果(COS-BC)问卷进行了回复。年龄匹配的乳腺钼靶检查结果为阴性的对照组(n = 499)在相同时间对COS-BC进行了回复。使用五个COS-BC量表(沮丧感、焦虑、行为、睡眠和存在价值)作为结局指标。
与对照组相比,乳腺钼靶筛查结果为假阳性的女性在所有五种后果方面的患病率一直较高(P < 0.001)。患病率在基线至6个月之间有所下降(P < 0.001),但在6至12个月之间保持稳定(P≥0.136)。早期召回对所有五个结局的长期后果有显著预测作用(OR,3.05 - 10.31),同时还包括对召回信息的不满(OR,2.28 - 2.56)、出生在国外(OR,2.35 - 3.71)以及缺乏社会支持(OR,1.13 - 1.25)。
这项为期1年的纵向研究表明,女性会经历乳腺钼靶筛查假阳性的心理社会后果。应谨慎进行早期召回,提供信息以及社会支持可能会减少心理社会后果。
虽然开展基于人群的筛查可降低乳腺癌死亡率,但也引发了其对健康女性心理社会福祉影响的问题。我们的研究结果确定了在未来努力减少乳腺钼靶筛查副作用时可针对的预测因素。